Exploiting the Natural Properties of Extracellular Vesicles in Targeted Delivery towards Specific Cells and Tissues

被引:41
作者
Lara, Pablo [1 ,2 ,3 ]
Chan, Alan B. [1 ]
Cruz, Luis J. [2 ]
Quest, Andrew F. G. [3 ,4 ]
Kogan, Marcelo J. [3 ,5 ]
机构
[1] Percuros BV, NL-2333 CL Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Translat Nanobiomat & Imaging TNI Grp, Dept Radiol, Albinusdreef 2, NL-2333 ZD Leiden, Netherlands
[3] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santos Dumont 964 Independencia, Santiago 8380000, Chile
[4] Univ Chile, Ctr Studies Exercise Metab & Canc CEMC, Lab Cellular Commun, Program Cell & Mol Biol,Inst Biomed Sci ICBM,Fac, Ave Independencia 1027, Santiago 8380453, Chile
[5] Univ Chile, Dept Quim Farmacol & Toxicol, Fac Ciencias Quim & Farmaceut, Santos Dumont 964 Independencia, Santiago 8380494, Chile
关键词
extracellular vesicles (EVs); exosomes; microvesicles; targeting; tracking; drug delivery; theranostics; INHIBIT IN-VITRO; PROGENITOR CELLS; DRUG-DELIVERY; STEM-CELLS; PLATELET MICROPARTICLES; GOLD NANOPARTICLES; ENDOTHELIAL-CELLS; CARDIAC-FUNCTION; DENDRITIC CELLS; MESSENGER-RNAS;
D O I
10.3390/pharmaceutics12111022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extracellular vesicles (EVs) are important mediators of intercellular communication that participate in many physiological/pathological processes. As such, EVs have unique properties related to their origin, which can be exploited for drug delivery applications in cell regeneration, immunosuppression, inflammation, cancer treatment or cardioprotection. Moreover, their cell-like membrane organization facilitates uptake and accumulation in specific tissues and organs, which can be exploited to improve selectivity of cargo delivery. The combination of these properties with the inclusion of drugs or imaging agents can significantly improve therapeutic efficacy and selectivity, reduce the undesirable side effects of drugs or permit earlier diagnosis of diseases. In this review, we will describe the natural properties of EVs isolated from different cell sources and discuss strategies that can be applied to increase the efficacy of targeting drugs or other contents to specific locations. The potential risks associated with the use of EVs will also be addressed.
引用
收藏
页码:1 / 25
页数:25
相关论文
共 150 条
[1]   Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics [J].
Abak, Atefe ;
Abhari, Alireza ;
Rahimzadeh, Sevda .
PEERJ, 2018, 6
[2]   Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles [J].
Adlerz, Katrina ;
Patel, Divya ;
Rowley, Jon ;
Ng, Kelvin ;
Ahsan, Tabassum .
STEM CELL RESEARCH, 2020, 48
[3]   Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[4]  
[Anonymous], 2019, Current Developments in Nutrition, V3, DOI DOI 10.1093/CDN/NZZ033.OR26-08-19
[5]   Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury [J].
Arslan, Fatih ;
Lai, Ruenn Chai ;
Smeets, Mirjam B. ;
Akeroyd, Lars ;
Choo, Andre ;
Aguor, Eissa N. E. ;
Timmers, Leo ;
van Rijen, Harold V. ;
Doevendans, Pieter A. ;
Pasterkamp, Gerard ;
Lim, Sai Kiang ;
de Kleijn, Dominique P. .
STEM CELL RESEARCH, 2013, 10 (03) :301-312
[6]   Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction [J].
Barile, Lucio ;
Lionetti, Vincenzo ;
Cervio, Elisabetta ;
Matteucci, Marco ;
Gherghiceanu, Mihaela ;
Popescu, Laurentiu M. ;
Torre, Tiziano ;
Siclari, Francesco ;
Moccetti, Tiziano ;
Vassalli, Giuseppe .
CARDIOVASCULAR RESEARCH, 2014, 103 (04) :530-541
[7]   VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers [J].
Bartolome, Ruben A. ;
Torres, Sofia ;
de Val, Soledad Isern ;
Escudero-Paniagua, Beatriz ;
Calvino, Eva ;
Teixido, Joaquin ;
Casal, J. Ignacio .
ONCOTARGET, 2017, 8 (01) :215-227
[8]   Using exosomes, naturally-equipped nanocarriers, for drug delivery [J].
Batrakova, Elena V. ;
Kim, Myung Soo .
JOURNAL OF CONTROLLED RELEASE, 2015, 219 :396-405
[9]   Interleukin 3-receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth [J].
Bellavia, Daniele ;
Raimondo, Stefania ;
Calabrese, Giovanna ;
Forte, Stefano ;
Cristaldi, Marta ;
Patinella, Agostina ;
Memeo, Lorenzo ;
Manno, Mauro ;
Raccosta, Samuele ;
Diana, Patrizia ;
Cirrincione, Girolamo ;
Giavaresi, Gianluca ;
Monteleone, Francesca ;
Fontana, Simona ;
De Leo, Giacomo ;
Alessandro, Riccardo .
THERANOSTICS, 2017, 7 (05) :1333-1345
[10]   Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC [J].
Besse, Benjamin ;
Charrier, Melinda ;
Lapierre, Valerie ;
Dansin, Eric ;
Lantz, Olivier ;
Planchard, David ;
Le Chevalier, Thierry ;
Livartoski, Alain ;
Barlesik, Fabrice ;
Laplanche, Agnes ;
Ploix, Stephanie ;
Vimond, Nadege ;
Peguillet, Isabelle ;
Thery, Clotilde ;
Lacroix, Ludovic ;
Zoernig, Inka ;
Dhodapkar, Kavita ;
Dhodapkar, Madhav ;
Viaud, Sophie ;
Soria, Jean-Charles ;
Reiners, Katrin S. ;
von Strandmann, Elke Pogge ;
Vely, Frederic ;
Rusakiewicz, Sylvie ;
Eggermont, Alexander ;
Pitt, Jonathan M. ;
Zitvogel, Laurence ;
Chaput, Nathalie .
ONCOIMMUNOLOGY, 2016, 5 (04)